VIM and Sepsis: To assess the therapeutic potential of the small-molecule vimentin modulator ALD-R491 in sepsis, we employed a cecal ligation and puncture (CLP)-induced sepsis model in mice, using mortality rate as the primary endpoint and disease severity as the secondary endpoint.